US IPO Lays Into EU Plans To Cut Data Protection & Extend ‘Bolar’ Exemption

 
• By Ian Schofield
  
Problems
The EU pharma review is throwing up a lot of questions • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography